Melatonin receptor (MT1/MT2)

Assets acting on this target.

Class
Melatonin receptor agonist
Notes
mechanism wave 2026-08-24 (DeepSeek draft; registry text of NCT06489327 names the target); source: https://clinicaltrials.gov/study/NCT06489327

Related mechanisms

Melatonin receptor (MT1/MT2) drugs compared

2 drugs, stage by indication
2 drugs acting on Melatonin receptor (MT1/MT2): developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
tasimelteonHetliozVanda Pharmaceuticalssmall moleculeApprovedApproved in Non-24-Hour Sleep-Wake Disorder
Melatonin prolonged-releaseCircadinNeurim Pharmaceuticals Ltd.Not recordedPhase 3Not recorded

← all mechanisms